1. Which of the following age groups recently received emergency authorization from the U.S. Food and Drug Administration for use of the Pfizer/BioNTech COVID-19 vaccine?
A. 12–15 year olds
B. 2–7 year olds
C. 6 month–2 year olds
D. 8–12 year olds
E. Unsure
2. Which of the following vaccines was associated with thrombosis with thrombocytopenia and cerebral venous sinus thrombosis in April 2021?
A. Janssen/Johnson & Johnson
B. Merck
C. Moderna
D. Pfizer/BioNTech
E. Unsure
3. Which of the following COVID-19 vaccines has been positively linked to infertility?
A. Janssen/Johnson & Johnson
B. Pfizer/BioNTech
C. Moderna
D. None of the above
E. Unsure
4. Which of the following is TRUE regarding administration of mRNA COVID-19 vaccines in pregnant patients?
A. These products should not be given to pregnant patients.
B. All pregnant patients should be given an adenovirus vector vaccine instead of an mRNA vaccine.
C. All pregnant patients may receive any authorized COVID-19 vaccine.
D. Pregnant patients must receive consult their healthcare provider before receiving any COVID-19 vaccine.
E. Unsure
5. Which of the following is the name of the smartphone-based program used to provide check-ins with patients after COVID-19 vaccination?
A. vHEFT
B. vSARS-CoV-2
C. v-safe
D. v-COVID-19
E. Unsure
6. How long does immunity last after vaccination with the mRNA vaccines?
A. 3 months
B. 6 months
C. 1 year
D. Unknown at this time
E. Unsure
7. For patients who are immunocompetent and fully vaccinated, in which of the following settings would masks be recommended by the U.S. Centers for Disease Control and Prevention?
A. Personal homes
B. Airplanes and airports
C. Outdoor parks
D. Personal automobiles
E. Unsure
8. Administration of which of the following manufacturer's COVID-19 vaccines must be separated from the influenza vaccine by 14 days?
A. Moderna
B. Janssen/Johnson & Johnson
C. Pfizer/BioNTech
D. None of the above
E. Unsure
9. Which of the following companies recently obtained approval to increase the number of doses of their vaccine in a single vial from 10 to 15
A. Moderna
B. Janssen/Johnson & Johnson
C. Merck
D. Pfizer/BioNTech
E. Unsure
10. Which of the following companies is studying a lyophilized formulation of its vaccine to avoid the need for ultracold storage?
A. Moderna
B. Janssen/Johnson & Johnson
C. Pfizer/BioNTech
D. Genentech
E. Unsure
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Will the information presented cause you to change your practice?
A. Yes
B. No
20. Are you committed to making these changes?
A. Yes
B. No
21. As a result of this activity, did you learn something new?
A. Yes
B. No
22. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
23. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20